```html

Palpable Ovarian Mass

What is Palpable Ovarian Mass?

A palpable ovarian mass is a growth or lump arising from an ovary that can be felt during a physical examination, either by a health‑care professional or, less commonly, by the patient herself. The term “palpable” simply means that the mass is large enough or positioned in a way that it can be felt through the abdominal wall or during a bimanual pelvic exam.

These masses can be benign (non‑cancerous) or malignant (cancerous). Most ovarian masses discovered in pre‑menopausal women are benign, such as functional cysts, whereas post‑menopausal women have a higher relative risk of malignancy. Because the ovaries are deep in the pelvis, a palpable mass often signifies that the lesion is sizable (usually >5 cm), rapidly growing, or located on the surface of the ovary.

Early detection is important because many ovarian conditions are treatable when caught early, while ovarian cancer frequently presents at an advanced stage. The information below outlines the most common causes, associated symptoms, when to seek care, how a diagnosis is made, treatment options, prevention tips, and emergency warning signs.

Common Causes

Below are the most frequent conditions that can present as a palpable ovarian mass. Some are completely benign, while others carry malignant potential.

• Functional ovarian cysts – Follicular or luteal cysts that develop as part of the normal menstrual cycle.
• Serous cystadenoma – A benign epithelial tumor filled with watery fluid.
• Mucinous cystadenoma – Large, multilocular cysts containing thick, mucinous fluid.
• Dermoid (mature cystic teratoma) – Contains hair, fat, or even teeth; usually benign.
• Endometriomas (chocolate cysts) – Result from endometriosis, where endometrial tissue implants on the ovary.
• Fibroma/thecoma – Solid, usually benign tumors that can cause a “fibro‑thecoma” syndrome with ascites.
• Polycystic ovary syndrome (PCOS) – Multiple small cysts can coalesce into a mass‑like ovary.
• Benign ovarian neoplasms (e.g., Brenner tumor).
• Borderline ovarian tumor – Low malignant potential; behaves between benign and invasive cancer.
• Ovarian cancer – Includes epithelial cancers (serous, mucinous, endometrioid), germ cell tumors, and stromal cancers.

Associated Symptoms

Many ovarian masses are discovered incidentally during routine exams or imaging for unrelated issues. When symptoms do appear, they often overlap with other gynecologic or gastrointestinal conditions.

• Abdominal bloating or a feeling of fullness
• Pelvic or lower‑abdominal pain—can be dull, cramp‑like, or sharp
• Pressure or heaviness in the groin or pelvis
• Changes in menstrual patterns (irregular periods, spotting)
• Urinary urgency or frequency (mass compressing the bladder)
• Constipation or a sense of incomplete bowel emptying
• Unexplained weight gain from fluid buildup (ascites) in advanced ovarian cancer
• Rapid increase in abdominal girth
• Post‑menopausal bleeding (if tumor secretes estrogen)
• General fatigue, night sweats, or unexplained fever (more typical of malignancy or infection)

When to See a Doctor

While a palpable mass isn’t automatically an emergency, prompt evaluation is essential, especially if any of the following occur:

• Persistent pelvic pain that does not improve with over‑the‑counter analgesics.
• Sudden, severe abdominal pain (possible rupture or torsion).
• Rapid increase in size of the mass over weeks.
• Bleeding between periods, heavy menstrual bleeding, or post‑menopausal bleeding.
• Changes in bowel or bladder habits that are new or worsening.
• Unexplained weight loss, loss of appetite, or constant fatigue.
• Any palpable mass found during a routine pelvic exam, especially after menopause.

If you fit any of these descriptions, schedule an appointment with a primary‑care physician, OB‑GYN, or gynecologic oncologist as soon as possible.

Diagnosis

Diagnosis of a palpable ovarian mass involves a stepwise approach combining history, physical exam, imaging, and sometimes laboratory testing.

1. Clinical History & Physical Examination

• Detailed menstrual, sexual, and obstetric history.
• Assessment of risk factors (family history of ovarian/breast cancer, BRCA mutation, personal history of endometriosis).
• Bimanual pelvic exam to estimate size, consistency (solid vs cystic), and mobility.

2. Imaging Studies

• Transvaginal pelvic ultrasound – First‑line; evaluates cyst characteristics (septations, solid components, papillary projections) and blood flow with Doppler.
• Transabdominal ultrasound – Useful for very large masses extending above the pelvis.
• Pelvic MRI – Provides superior soft‑tissue detail for indeterminate masses.
• CT scan – Often used when cancer spread (staging) is suspected.

3. Laboratory Tests

• CA‑125 – Elevated in many ovarian cancers but can also rise with endometriosis, fibroids, or pelvic inflammation.
• HE4 (human epididymis protein 4) – Used with CA‑125 in the ROMA algorithm to estimate malignancy risk.
• Other tumor markers (AFP, β‑hCG, LDH) when germ cell tumors are suspected.

4. Risk Stratification Tools

Algorithms such as the International Ovarian Tumor Analysis (IOTA) Simple Rules, the Risk of Malignancy Index (RMI), or the ROMA score help clinicians decide whether surgery should be performed by a gynecologic oncologist.

5. Surgical Evaluation

If imaging suggests a complex or potentially malignant mass, the definitive diagnosis is often made intra‑operatively and confirmed by pathology (histopathology). Laparoscopy or laparotomy may be employed based on size, suspicion of cancer, and surgeon expertise.

Treatment Options

Treatment is tailored to the underlying cause, patient’s age, desire for fertility, and overall health. Below are the main therapeutic avenues.

1. Observation (Watchful Waiting)

• Appropriate for simple, thin‑walled functional cysts < 5 cm that are asymptomatic.
• Repeat ultrasound in 6–12 weeks to ensure resolution.
• Most functional cysts resolve spontaneously.

2. Medical Management

• Hormonal contraceptives (combined oral pills, progestin‑only pills, or intrauterine systems) can suppress ovulation and reduce recurrence of functional cysts.
• GnRH agonists may shrink endometriomas before surgery, though they are not first‑line due to side effects.

3. Surgical Treatment

• Laparoscopy – Preferred for benign‑appearing masses < 10 cm; offers quicker recovery.
• Laparotomy – Used for large (>10 cm), suspicious, or malignant masses; allows comprehensive staging.
• Procedures may include:
  • Cystectomy (removal of cyst while preserving ovary) – fertility‑preserving.
  • Oophorectomy (removal of one ovary) – for solid or recurrent masses.
  • Salpingo‑oophorectomy (removal of ovary and fallopian tube) – when malignancy is suspected.
  • Total hysterectomy with bilateral salpingo‑oophorectomy – for advanced ovarian cancer.

4. Chemotherapy & Targeted Therapy (for Malignancy)

• Standard regimen for epithelial ovarian cancer: carboplatin + paclitaxel, often given every 3 weeks for 6 cycles.
• Bevacizumab (anti‑VEGF) or PARP inhibitors (olaparib, niraparib) for BRCA‑mutated or recurrent disease.
• Clinical trial enrollment is encouraged when appropriate.

5. Supportive & Home Care

• Heat packs or ibuprofen for mild pain (if no contraindications).
• Maintain a balanced diet rich in fruits, vegetables, and whole grains.
• Limit caffeine and alcohol which can exacerbate pelvic discomfort.
• Regular moderate exercise improves circulation and may reduce risk of torsion.

Prevention Tips

While not all ovarian masses are preventable, certain lifestyle and medical strategies can lower risk, especially for benign growths and ovarian cancer.

• Use combined oral contraceptives for at least 5 years – associated with a 20–30 % reduction in ovarian cancer risk.
• Maintain a healthy weight; obesity is linked to higher ovarian cancer incidence.
• Adopt a diet high in antioxidants (berries, leafy greens) and low in processed meats.
• Stay physically active – at least 150 minutes of moderate aerobic activity per week.
• Consider genetic counseling if you have a strong family history of breast/ovarian cancer; BRCA testing can guide risk‑reducing strategies.
• For women with known endometriosis, regular follow‑up with an OB‑GYN can catch endometriomas early.
• Avoid smoking; tobacco exposure is a known risk factor for many cancers, including ovarian.
• Discuss prophylactic surgery (bilateral salpingo‑oophorectomy) with a specialist if you carry high‑risk mutations and have completed childbearing.

Emergency Warning Signs

Seek immediate medical attention (go to the emergency department or call emergency services) if you experience any of the following:

• Sudden, severe abdominal or pelvic pain – possible ovarian torsion or rupture.
• Rapid onset of dizziness, fainting, or a significant drop in blood pressure – suggests internal bleeding.
• Persistent vomiting or inability to keep fluids down.
• High fever (≥38.5 °C / 101.3 °F) with chills – could indicate infection or abscess.
• Acute swelling of the abdomen accompanied by shortness of breath – may signal massive ascites or tumor rupture.

These situations can be life‑threatening and require prompt evaluation and possible surgical intervention.

---

**References**

• Mayo Clinic. “Ovarian cysts.” https://www.mayoclinic.org. Accessed June 2026.
• American College of Obstetricians and Gynecologists (ACOG). “Practice Bulletin No. 174: Ovarian Cysts.” https://www.acog.org.
• National Cancer Institute. “Ovarian Cancer Treatment (PDQ®)–Patient Version.” https://www.cancer.gov.
• Cleveland Clinic. “Ovarian Cancer Symptoms, Diagnosis, and Treatment.” https://my.clevelandclinic.org.
• World Health Organization. “WHO Classification of Tumours of Female Reproductive Organs, 5th edition.” 2024.
• Society of Gynecologic Oncology. “Guidelines for the Management of Ovarian Masses.” 2023.

```